Minerva Neurosciences NERV
NASDAQ NERV
$3.35 -0.05 (-1.47%)
At close: Sep 29, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Operating Expenses (2013 - 2026)

Updated

Minerva Neurosciences (NERV) recorded Operating Expenses of $10.64 million in Q2 2026, up 215.4% from $3.37 million a year earlier but down 36.2% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Operating Expenses (2013 - 2026) Analysis & Trends

On a TTM basis, Minerva Neurosciences' Operating Expenses came in at $35.14 million as of Jun 30, 2026, up 117.4% year-over-year; for FY2025, it came in at $15.1 million, down 30.9% from FY2024.

  • Annual Operating Expenses has declined for four straight years, with a five-year compound annual growth rate of -17.4% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $21.85 million in FY2024 (-5.5%), $23.12 million in FY2023 (-8.4%), $25.23 million in FY2022 (-44.4%) and $45.37 million in FY2021 (+15.3%).
  • Quarterly Operating Expenses has ranged from $2.84 million in Q3 2025 to $21.38 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Operating Expenses has increased for three consecutive quarters, with growth averaging 45.6% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 327.2% in Q1 2026, against a decline of 76.3% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $16.67 million (Q1 2026), $4.98 million (Q4 2025) and $2.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Minerva Neurosciences 160.57 Mn 160.57 Mn - 10.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.64 Mn
Mar 31, 2026 16.67 Mn
Dec 31, 2025 4.98 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 3.37 Mn
Mar 31, 2025 3.90 Mn
Dec 31, 2024 4.52 Mn
Sep 30, 2024 4.37 Mn
Jun 30, 2024 6.28 Mn
Mar 31, 2024 6.68 Mn
Dec 31, 2023 7.17 Mn
Sep 30, 2023 6.08 Mn
Jun 30, 2023 4.52 Mn
Mar 31, 2023 5.35 Mn
Dec 31, 2022 5.07 Mn
Sep 30, 2022 5.21 Mn
Jun 30, 2022 6.97 Mn
Mar 31, 2022 7.99 Mn
Dec 31, 2021 21.38 Mn
Sep 30, 2021 7.52 Mn
API Access

Minerva Neurosciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEY